AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1743242
Drug: Transdermal delivery
RxNorm normalized name: nitroglycerin 5 mg in 1 d TRANSDERMAL PATCH [Nitroglycerin Transdermal Delivery System]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal delivery system (TDS) with phasic release of glyceryl trinitrate (GTN)
Trial: 28982672
Drug: Extended-release torsemide
RxNorm normalized name: Torsemide
DrugBank: Torasemide (DB00214)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended-release torsemide
Trial: 11888512
Drug: HMG CoA
RxNorm normalized name: HMG CoA reductase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG CoA RI therapy (pravastatin 40 mg QD or simvastatin 20 mg QD)
Trial: 16926581
Drug: Interdisciplinary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interdisciplinary treatment
Trial: 15592276
Drug: Goserelin injection
DrugBank: Goserelin (DB00014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Goserelin injection (3.6 mg/month)
Trial: 14629242
Drug: Almotriptan 12.5
RxNorm normalized name: almotriptan 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almotriptan 12.5 mg
Trial: 1872271
Drug: Felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5 mg and 10 mg
Trial: 9291168
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIg) 0.15-0.2 g/kg body weight, administered monthly for 2 years
Trial: 30682359
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen 1000 mg
Trial: 25912040
Drug: Experimental soy-based
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental soy-based formula 1 (EF1) containing scFOS (2.5 g/L) and mixed carotenoids
Trial: 28522078
Drug: Oral appliance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral appliance therapy (OAT)
Trial: 15633323
Drug: Anesthetic gel
RxNorm normalized name: Topicaine 4% Topical Anesthetic Gel
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anesthetic gel
Trial: 3651264
Drug: Split-course radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Split-course radiation therapy with a 5-week rest interval
Trial: 9177549
Drug: Melatonin 5
RxNorm normalized name: melatonin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 5 mg
Trial: 3117400
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (MMC) group, intravesical instillation with 30 mg MMC dissolved in 100 ml physiological saline; administered six times within 2 weeks, then every 4 weeks for 2 years.
Trial: 11137327
Drug: Transdermal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormone replacement therapy with E2 (50 microg/day) and NETA (350 microg/day)
Trial: 30194765
Drug: Therapeutic levels
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic levels of hypoglossal nerve stimulation therapy (HGNS)
Trial: 22093109
Drug: Synbiotics treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotics treatment
Trial: 15963058
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose testosterone (Te) supplementation
Trial: 9480468
Drug: Prophylactic antibiotic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotic regimen (gentamicin, clindamycin)
Trial: 9480468
Drug: Curative antibiotic
RxNorm normalized name: CUR-1916
DrugBank: CUR-1916 (DB17838)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curative antibiotic treatment (intraoperatively)
Trial: 29627296
Drug: Extended-release niacin
RxNorm normalized name: niacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release niacin (ERN)
Trial: 7019300
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment consisting of preliminary chemotherapy (AVM or CMF), radiotherapy, and follow-up adjuvant chemotherapy.
Trial: 16123103
Drug: Substance P
RxNorm normalized name: Substance P
DrugBank: Substance P (DB19198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substance P + 10 mm L-NAME
Trial: 28120631
Drug: Minimal intervention
RxNorm normalized name: Centipeda minima whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal intervention (monthly written information bulletins and monthly phone calls)
Trial: 23884046
Drug: 4-week educational
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week educational intervention involving weekly 60-minute sessions (Group A)
Trial: 15872036
Drug: Pexelizumab 24
RxNorm normalized name: Pexelizumab
DrugBank: Pexelizumab (DB04949)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pexelizumab 24 h infusion
Trial: 10695381
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic hormone concentration in blood serum
Trial: 19425819
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration exercise (static and dynamic tasks) twice a week for six weeks
Trial: 25942666
Drug: Body Cream
RxNorm normalized name: Udderly Smooth Body Cream
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body Cream (moisturizer group)
Trial: 25942666
Drug: Flare Treatment
RxNorm normalized name: Flarex
DrugBank: Fluorometholone (DB00324)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flare Treatment
Trial: 17287406
Drug: Elevated thyrotropin
RxNorm normalized name: Thyrotropin
DrugBank: Thyrotropin (DB15263)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated thyrotropin receptor antibody
Trial: 17287406
Drug: Thyroid hormone
RxNorm normalized name: Thyroid hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid hormone state (including subclinical thyrotoxicosis)
Trial: 8960832
Drug: Continuous intraperitoneal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intraperitoneal insulin infusion (CPII) for 12 months
Trial: 6452833
Drug: Pulverized tablets
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulverized tablets of salbutamol, theophylline, and their combination
Trial: 15221507
Drug: Taurine 3
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine 3 g/day for 7 weeks
Trial: 21343579
Drug: Nitroglycerin ointment
RxNorm normalized name: Nitroglycerin Ointment
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin ointment (15 mg/d)
Trial: 15164191
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg slow-release valproic acid (VPA)
Trial: 15164191
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg slow-release levodopa (LD) + 50 mg benserazid
Trial: 2240530
Drug: Famotidine 20
RxNorm normalized name: famotidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 20 mg orally the night before surgery and 20 mg intramuscularly 60 minutes before induction of anaesthesia
Trial: 83189
Drug: Isoprinosine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoprinosine treatment
Trial: 16860976
Drug: Korean red
RxNorm normalized name: Korean ginseng root
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Korean red ginseng (KRG) preparation (2 g/meal=6 g/day) for 12 weeks
Trial: 11850287
Drug: GW 420867X
RxNorm normalized name: GW 468816
DrugBank: GW 468816 (DB05417)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GW 420867X 100 mg
Trial: 17257231
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) infusion (0.5 microg/kg/min for 20 min)
Trial: 19298364
Drug: Parecoxib 40
RxNorm normalized name: Parécoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib 40 mg i.v. (Group IIa, n=57)
Trial: 9554680
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with chlorthalidone and atenolol (or reserpine)
Trial: 10068849
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for 7 days
Trial: 8495454
Drug: Domperidone 20
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone 20 mg plus paracetamol 1 g
Trial: 7890009
Drug: HELP-apheresis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HELP-apheresis treatment
Trial: 22992296
Drug: 6-week nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 6-week nicotine patch only
Trial: 23927381
Drug: Capsule containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule containing fish oil (Control)
Trial: 26205759
Drug: Tacrolimus with
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus with oral prednisolone (TAC*)
Trial: 26840902
Drug: Sumatriptan NS
RxNorm normalized name: NS-2359
DrugBank: NS-2359 (DB05805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan NS 20 mg
Trial: 25425730
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate (1000 mg/once daily) plus prednisolone (5 mg/twice daily)
Trial: 2124732
Drug: Diazepam enema
RxNorm normalized name: diazepam Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam enema (0.5 mg/kg bodyweight)
Trial: 9797051
Drug: Tetracycline HCl
RxNorm normalized name: tetracycline HCl
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline HCl (TTC) 10 mg/ml
Trial: 9857541
Drug: Ultrasound technique
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound technique for prosthetic treatment planning and observation
Trial: 2821953
Drug: Nortriptyline hydrochloride
RxNorm normalized name: Nortriptyline Hydrochloride
DrugBank: Nortriptyline (DB00540)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nortriptyline hydrochloride and electroconvulsive therapy
Trial: 27553623
Drug: Sham (placebo)
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham (placebo) treatment
Trial: 11789260
Drug: Jinshuibao capsule
RxNorm normalized name: Jinshuibao
DrugBank: Ophiocordyceps sinensis (DB19288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jinshuibao capsule (JSBC) for 48 weeks
Trial: 8697308
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg ramipril
Trial: 3034021
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of ramipril
Trial: 11345282
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate dry powder inhaler (MF-DPI) 400 microg twice daily
Trial: 11345282
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate dry powder inhaler (MF-DPI) 200 microg twice daily
Trial: 11345282
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate dry powder inhaler (MF-DPI) 100 microg twice daily
Trial: 10503166
Drug: Lentinan 2
RxNorm normalized name: lentinan
DrugBank: Lentinan (DB13480)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lentinan 2 mg i.v. once a week for eight weeks
Trial: 7908246
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (200 micrograms)
Trial: 9050956
Drug: Continuous intrathecal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intrathecal baclofen infusion (CIBI)
Trial: 7267673
Drug: Cephalexin 500
RxNorm normalized name: cephalexin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalexin 500 mg twice daily
Trial: 18841288
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg clopidogrel and acetylsalicylic acid (ASA)
Trial: 19825916
Drug: lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: lactated Ringer's (RL) solution
Trial: 11212591
Drug: Tricyclic antidepressants
RxNorm normalized name: TRICYCLIC ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tricyclic antidepressants
Trial: 15217841
Drug: Weekly home
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly home visits by community health aides for one year in addition to usual duties
Trial: 11515711
Drug: Clarithromycin formulation
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin formulation 1 and 2
Trial: 8877335
Drug: Ulfon Lyoc
RxNorm normalized name: Dimethyl sulfone
DrugBank: Dimethyl sulfone (DB14090)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulfon Lyoc in lyophilised tablet form (group 1; n = 40)
Trial: 28027682
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (placebo ointment)
Trial: 26581685
Drug: Milk-based protein
RxNorm normalized name: milk protein concentrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk-based protein matrix (0.165 g/kg body mass)
Trial: 11435249
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 100 microg twice a day
Trial: 20062928
Drug: DZ-697b 60
RxNorm normalized name: DA-697b
DrugBank: DA-697b (DB06001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DZ-697b 60 mg
Trial: 18048822
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (high-dose and conventional-dose chemotherapy)
Trial: 25512407
Drug: Vehicle control
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle control (0 mg)
Trial: 11731185
Drug: Estradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol valerate (2 mg) for 21 days
Trial: 21093467
Drug: Preferred RP
RxNorm normalized name: RP-72
DrugBank: RP-72 (DB17156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preferred RP dose (1.8 ± 0.3 g/meal for spicy food users, 0.3 ± 0.1 g/meal for non-users)
Trial: 21093467
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g red pepper (RP)
Trial: 19179979
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (30 mg/kg bolus, 500 mg/h infusion)
Trial: 9829494
Drug: Subcutaneous rHuEpo
RxNorm normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous rHuEpo (100 U/kg)
Trial: 28333187
Drug: Eldelumab 20
RxNorm normalized name: Eldelumab
DrugBank: Eldelumab (DB06116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eldelumab 20 mg/kg
Trial: 28333187
Drug: Eldelumab 10
RxNorm normalized name: Eldelumab
DrugBank: Eldelumab (DB06116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eldelumab 10 mg/kg
Trial: 2857265
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet with lower polyunsaturated to saturated fat ratio and placebo supplement
Trial: 1678031
Drug: Preincubation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preincubation of platelets with aspirin (10 mumol/l)
Trial: 20619353
Drug: Indacaterol 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 300 μg
Trial: 9708631
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate 160 mg daily (LMA)
Trial: 9708631
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate 480 mg daily (HMA)
Trial: 22469418
Drug: Natural S-equol
RxNorm normalized name: S-equol
DrugBank: Equol (DB11674)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural S-equol (10 mg S-equol daily for 12 weeks)
Trial: 24696094
Drug: Bitopertin 10
RxNorm normalized name: Bitopertin
DrugBank: Bitopertin (DB12426)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitopertin 10 mg/d
Trial: 28058763
Drug: Serious hypoglycaemia
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Serious hypoglycaemia (combined treatment groups)
Trial: 2182732
Drug: 7-day trimethoprim
RxNorm normalized name: Trimethoprim
DrugBank: Trimethoprim (DB00440)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 7-day trimethoprim treatment
Trial: 30648303
Drug: Usual REMS
RxNorm normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Usual REMS treatments alone (n=11)
Trial: 7505351
Drug: Nitrendipine (NTR)
RxNorm normalized name: nitrendipine
DrugBank: Nitrendipine (DB01054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (NTR) 10 mg, adjusted to 20 mg if necessary
Trial: 31356229
Drug: Eluxadoline 100
RxNorm normalized name: eluxadoline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eluxadoline 100 mg twice daily for 12 weeks
Trial: 15126582
Drug: 2 or
RxNorm normalized name: CP-2 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 or 5 mg mifepristone daily for 120 days
Trial: 19535229
Drug: Standard olanzapine
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard olanzapine tablets (SOT)
Trial: 21246365
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment methods
Trial: 17323096
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no platelet gel and fibrin sealant)
Trial: 31118595
Drug: Testosterone treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone treatment
Trial: 12803576
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of extended-release aspirin (ERASA)
Trial: 15452780
Drug: Epinephrine injection
RxNorm normalized name: epinephrine Injection
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine injection (in polyps >= 2 cm)
Trial: 25325911
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy in the fifth protocol (n=46)
Trial: 24787495
Drug: Sucrose supplementation
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose supplementation (2 g/kg body weight)
Trial: 19879555
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application
Trial: 30689759
Drug: Doxycycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (100 mg twice daily for 7 days)
Trial: 637293
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of etomidate
Trial: 27517842
Drug: Higher initial
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Higher initial opioid dose (mg/kg/hr of morphine equivalents)